Clinical trial Recruiting at 1 site Interventional Ages 20 to 60

Nebulized ketamine versus nebulized dexmedetomidine for pain control after endoscopic nasal surgery

Official title: Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries

Run by Sohag University · NCT07056582 · Data updated 2026-11-12

This trial will test whether inhaled (nebulized) ketamine or inhaled dexmedetomidine provides better pain relief after endoscopic nasal surgery for adults aged 20 to 60.

Quick facts

Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment105 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedApril 14, 2025
Main results expectedOctober 20, 2025
Study endsOctober 20, 2025
Registry record updatedJuly 9, 2025
Trial IDNCT07056582 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 20–60 years old scheduled for endoscopic nasal surgery who are ASA physical status I–II with BMI between 18 and 30, not pregnant or breastfeeding, and without significant organ or psychiatric disease.

Probably not a fit

Patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women, those with drug allergies, recent CNS depressant or analgesic use, or unstable blood pressure/heart rate are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants scheduled for endoscopic nasal surgery receive a pre-emptive nebulized dose of ketamine, nebulized dexmedetomidine, or saline before anesthesia, and postoperative pain scores and analgesic consumption are recorded. The trial enrolls ASA I–II adults aged 20–60 with BMI 18–30 and excludes those with major organ disease, pregnancy, recent CNS depressant use, or hemodynamic instability. Pain is measured at standardized postoperative time points using validated pain scales, and vital signs are monitored for drug-related effects. The goal is to identify which nebulized agent gives better immediate postoperative analgesia and whether either reduces opioid requirements.

Why it matters

Potential benefit: If successful, one of the nebulized drugs could offer better immediate pain relief after endoscopic nasal surgery and reduce the need for opioid painkillers.

How similar studies have gone: Smaller studies and case series have reported that nebulized ketamine or dexmedetomidine can reduce postoperative pain in airway and minor surgical settings, but direct head-to-head comparisons are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients between the ages of 20 and 60,
* both sexes,
* American Society of Anesthesiologists physical status I to II
* BMI ≥18≤30 kg/m²

Exclusion Criteria:

* Patient refusal.
* patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
* patients with a history of allergies to any study drugs.
* patients who had used central nervous system depressants or analgesics within the previous 24 hours.
* patients with hypertension, hypotension, or bradycardia.

Where it's running

  • Sohag university hospital
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.